Literature DB >> 25125072

Optical quality of the diabetic eye: a review.

A M Calvo-Maroto1, R J Perez-Cambrodí2, C Albarán-Diego1, A Pons1, A Cerviño1.   

Abstract

Diabetes mellitus is a metabolic disorder characterized by the presence of chronic hyperglycaemia. Several structural, morphological, and physiological changes in each of ocular component have been described in detail during the past decades. Due to these abnormalities, the diabetic patient undergoes a degradation of the retinal image by an increase of higher ocular aberrations and ocular scattering coming from mainly tear film, cornea, and crystalline lens. This review aims to provide an overview of current knowledge about the effects of diabetes mellitus in these optical phenomena and its consequence on the visual quality of the diabetic patient.

Entities:  

Mesh:

Year:  2014        PMID: 25125072      PMCID: PMC4274279          DOI: 10.1038/eye.2014.176

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  93 in total

1.  Ocular aberrations before and after myopic corneal refractive surgery: LASIK-induced changes measured with laser ray tracing.

Authors:  E Moreno-Barriuso; J M Lloves; S Marcos; R Navarro; L Llorente; S Barbero
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-05       Impact factor: 4.799

2.  CHANGES IN REFRACTION IN DIABETES MELLITUS.

Authors:  W S Duke-Elder
Journal:  Br J Ophthalmol       Date:  1925-04       Impact factor: 4.638

3.  Supernormal vision and high-resolution retinal imaging through adaptive optics.

Authors:  J Liang; D R Williams; D T Miller
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  1997-11       Impact factor: 2.129

4.  Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus.

Authors:  M Dogru; C Katakami; M Inoue
Journal:  Ophthalmology       Date:  2001-03       Impact factor: 12.079

5.  Biometric, optical and physical changes in the isolated human crystalline lens with age in relation to presbyopia.

Authors:  A Glasser; M C Campbell
Journal:  Vision Res       Date:  1999-06       Impact factor: 1.886

6.  Diurnal variation of corneal autofluorescence in normal and diabetic eyes.

Authors:  N Kitaya; S Ishiko; F Mori; T Abiko; H Kagokawa; M Takeda; A Takamiya; A Yoshida
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

7.  Prevalence of cataracts in a population-based study of persons with diabetes mellitus.

Authors:  B E Klein; R Klein; S E Moss
Journal:  Ophthalmology       Date:  1985-09       Impact factor: 12.079

8.  Protective role of oral antioxidant supplementation in ocular surface of diabetic patients.

Authors:  V Peponis; M Papathanasiou; A Kapranou; C Magkou; A Tyligada; A Melidonis; T Drosos; N M Sitaras
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

9.  Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.

Authors:  A W Stitt; J E Moore; J A Sharkey; G Murphy; D A Simpson; R Bucala; H Vlassara; D B Archer
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-12       Impact factor: 4.799

10.  Wavefront analysis of higher order aberrations in dry eye patients.

Authors:  Robert Montés-Micó; Araceli Cáliz; Jorge L Alió
Journal:  J Refract Surg       Date:  2004 May-Jun       Impact factor: 3.573

View more
  18 in total

Review 1.  Diabetic complications in the cornea.

Authors:  Alexander V Ljubimov
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

2.  Recovery of Corneal Sensitivity and Increase in Nerve Density and Wound Healing in Diabetic Mice After PEDF Plus DHA Treatment.

Authors:  Jiucheng He; Thang Luong Pham; Azucena Kakazu; Haydee E P Bazan
Journal:  Diabetes       Date:  2017-06-07       Impact factor: 9.461

3.  Normalization of wound healing and stem cell marker patterns in organ-cultured human diabetic corneas by gene therapy of limbal cells.

Authors:  Mehrnoosh Saghizadeh; Christian M Dib; William J Brunken; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2014-10-30       Impact factor: 3.467

4.  Metformin attenuated histopathological ocular deteriorations in a streptozotocin-induced hyperglycemic rat model.

Authors:  Nazmun Nahar; Suhaila Mohamed; Noordin Mohamed Mustapha; SengFong Lau; Nur Iliyani Mohd Ishak; Norshahira Solehah Umran
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-13       Impact factor: 3.000

5.  Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells.

Authors:  Andrei A Kramerov; Mehrnoosh Saghizadeh; Alexander V Ljubimov
Journal:  J Vis Exp       Date:  2016-04-07       Impact factor: 1.355

Review 6.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

7.  Diabetic Uterine Environment Leads to Disorders in Metabolism of Offspring.

Authors:  Ming-Zhe Dong; Qian-Nan Li; Li-Hua Fan; Li Li; Wei Shen; Zhen-Bo Wang; Qing-Yuan Sun
Journal:  Front Cell Dev Biol       Date:  2021-07-26

8.  Central corneal thickness and its determinants in a geriatric population: a population-based study.

Authors:  Hassan Hashemi; Payam Nabovati; Mohammadreza Aghamirsalim; Abbasali Yekta; Farhad Rezvan; Mehdi Khabazkhoob
Journal:  Eye (Lond)       Date:  2022-02-01       Impact factor: 4.456

9.  Persistence of reduced expression of putative stem cell markers and slow wound healing in cultured diabetic limbal epithelial cells.

Authors:  Andrei A Kramerov; Mehrnoosh Saghizadeh; Ezra Maguen; Yaron S Rabinowitz; Alexander V Ljubimov
Journal:  Mol Vis       Date:  2015-12-30       Impact factor: 2.367

10.  Effect of diabetic retinopathy and diabetes on the intraocular straylight in pseudophakic eyes.

Authors:  Hyung Bin Hwang; Hye Bin Yim; Sung Kun Chung
Journal:  BMC Ophthalmol       Date:  2015-10-13       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.